Loss of 3p26.3 is an independent prognostic factor in patients with oral squamous cell carcinoma

Oncology Reports

Volumn 26, Issue 2, 2011, Pages 463-469

  Uchida, Kenichiro ^a   Oga, Atsunori ^a   Nakao, Motonao ^a   Mano, Takamitsu ^a   Mihara, Mariko ^a   Kawauchi, Shigeto ^a   Furuya, Tomoko ^a   Ueyama, Yoshiya ^a   Sasaki, Kohsuke ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Array based comparative genomic hybridization; Loss of 3p26.3; Prognosis; Squamous cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; DNA; PROTEIN CHL1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHL1 GENE; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 20Q; CHROMOSOME 2P; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 7P; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOME ANALYSIS; GENOME SIZE; HUMAN; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; COMPARATIVE GENOMIC HYBRIDIZATION; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS;

EID: 79958241555     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1327     Document Type: Article

References (42)

1. Ferlay J, Parkin DM and Pisani P: GLOBOCAN 1: Cancer Incidence and Mortality Worldwide. IARC CancerBase No 3. International Agency for Research on Cancer, Lyon, 1998.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
3. Vokes EE, Weichselbaum RR, Lippman SM and Hong WK: Head and neck cancer. N Engl J Med 328: 184-194, 1993.
4. Parker SL, Tong T, Bolden S and Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 46: 5-27, 1996.
5. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992.
6. Hashimoto Y, Oga A, Okami K, Imate Y, Yamashita Y and Sasaki K: Relationship between cytogenetic aberrations by CGH coupled with tissue microdissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma. Cytometry 40: 161-166, 2000. (Pubitemid 30322379)
7. Hashimoto Y, Oga A, Kawauchi S, et al: Amplification of 3q26 approximately qter correlates with tumor progression in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 129: 52-56, 2001. (Pubitemid 32743380)
8. Okafuji M, Ita M, Hayatsu Y, Shinozaki F, Oga A and Sasaki K: Identification of genetic aberrations in cell lines from oral squamous cell carcinomas by comparative genomic hybridization. J Oral Pathol Med 28: 241-245, 1999. (Pubitemid 29298246)
9. Okafuji M, Ita M, Oga A, et al: The relationship of genetic aberrations detected by comparative genomic hybridization to DNA ploidy and tumor size in human oral squamous cell carcinomas. J Oral Pathol Med 29: 226-231, 2000. (Pubitemid 30244487)
10. Oga A, Kong G, Tae K, Lee Y and Sasaki K: Comparative genomic hybridization analysis reveals 3q gain resulting in genetic alteration in 3q in advanced oral squamous cell carcinoma. Cancer Genet Cytogenet 127: 24-29, 2001. (Pubitemid 32530089)
11. Califano J, van der Riet P, Westra W, et al: Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-2492, 1996. (Pubitemid 26170679)
12. Lippman SM and Hong WK: Molecular markers of the risk of oral cancer. N Engl J Med 344: 1323-1326, 2001. (Pubitemid 32372968)
13. Partridge M, Emilion G, Pateromichelakis S, Phillips E and Langdon J: Location of candidate tumour suppressor gene loci at chromosomes 3p, 8p and 9p for oral squamous cell carcinomas. Int J Cancer 83: 318-325, 1999. (Pubitemid 29455754)
14. Mao L, Lee JS, Fan YH, et al: Frequent micro satellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 2: 682-685, 1996. (Pubitemid 26191956)
15. Solinas-Toldo S, Lampel S, Stilgenbauer S, et al: Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosom Cancer 20: 399-407, 1997. (Pubitemid 27520090)
16. Pinkel D, Segraves R, Sudar D, et al: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: 207-211, 1998. (Pubitemid 28455458)
17. Nakao K, Mehta KR, Fridlyand J, et al: High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25: 1345-1357, 2004. (Pubitemid 39162701)
18. Cho YL, Bae S, Koo MS, et al: Array comparative genomic hybridization analysis of uterine leiomyosarcoma. Gynecol Oncol 99: 545-551, 2005. (Pubitemid 41686534)
19. Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, Shieh TM and Chang KW: Genome-wide profiling of oral squamous cell carcinoma. J Pathol 204: 326-332, 2004. (Pubitemid 39430093)
20. Baldwin C, Garnis C, Zhang L, Rosin MP and Lam WL: Multiple microalterations detected at high frequency in oral cancer. Cancer Res 65: 7561-7567, 2005. (Pubitemid 41297225)
21. Liu CJ, Lin SC, Chen YJ, Chang KM and Chang KW: Array- comparative genomic hybridization to detect genome-wide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog 45: 721-731, 2006.
22. Sobin LH and Wittekind CH: Lip and oral cavity. In: TNM Classification of Malignant Tumours. 6th edition. Sobin LH and Wittekind CH (eds). Wiley-Liss Inc., New York, pp22-26, 2002.
23. Yamamoto Y, Chochi Y, Matsuyama H, et al: Gain of 5p15.33 is associated with progression of bladder cancer. Oncology 72: 132-138, 2007. (Pubitemid 350249141)
24. Hwang KT, Han W, Cho J, et al: Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer 123: 1807-1815, 2008.
25. Freier K, Joos S, Flechtenmacher C, et al: Tssue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 63: 1179-1182, 2003. (Pubitemid 36348691)
26. Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki Y and Amagasa T: Cylin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Cancer 104: 2709-2716, 2005. (Pubitemid 41798281)
27. Shuster MI, Han L, Le Beau MM, et al: A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 28: 153-163, 2000. (Pubitemid 30246993)
28. Miyamoto R, Uzawa N, Nagaoka S, Nakakuki K, Hirata Y and Amagasa T: Potential marker of oral squamous cell carcinoma aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies. Cancer 95: 2152-2159, 2002. (Pubitemid 35253377)
29. Dai Z, Zhu WG, Morrison CD, et al: A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes. Hum Mol Genet 12: 791-801, 2003. (Pubitemid 36416965)
30. Kawaguchi S, Harada K, Supriatno, Yoshida H and Sato M: Overexpression of tuberous sclerosis complex 2 exerts antitumor effect on oral cancer cell lines. Oral Oncol 39: 836-841, 2003. (Pubitemid 38373468)
31. Wienecke R, Konig A and DeClue JE: Identification of tuberin, the tuberous sclerosis 2 product. Tuberin possesses specificRap1 GAP activity. J Biol Chem 270: 16409-16414, 1995.
32. Soucek T, Yeung RS and Hengstschlager M: Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene 2. Proc Natl Acad Sci USA 95: 15653-15658, 1998. (Pubitemid 29018755)
33. Kochetkova M, McKenzie OL, Bais AJ, et al: CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. Cancer Res 62: 4599-4604, 2002.
34. Härkönen P, Kyllönen AP, Nordling S and Vihko P: Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer. Prostate 62: 267-274, 2005. (Pubitemid 40129065)
35. Mosse YP, Greshock J, Margolin A, et al: High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 43: 390-403, 2005. (Pubitemid 40946474)
36. Camps J, Armengol G, del Rey J, et al: Genome-wide differences between microsatellite stable and unstable colorectal tumors. Carcinogenesis 27: 419-428, 2006. (Pubitemid 43372871)
37. Schlaeger C, Longerich T, Schiller C, et al: Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. Hepatology 47: 511-520, 2008. (Pubitemid 351280719)
38. Ueno T, Tangoku A, Yoshino S, et al: Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Pes 8: 526-533, 2002. (Pubitemid 34193973)
39. Robledo C, García JL, Caballero D, et al: Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas. Cancer 115: 3728-3737, 2009.
40. Lin SC, Chen YJ, Kao SY, et al: Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters. Oral Oncol 38: 266-273, 2002.
41. Demyanenko GP, Schachner M, Anton E, Schmid R, Feng G, Sanes J and Maness PF: Close homolog of L1 modulates area-specific neuronal positioning and dendrite orientation in the cerebral cortex. Neuron 44: 423-437, 2004. (Pubitemid 39423345)
42. Qin YR, Fu L, Sham PC, et al: Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. Int J Cancer 123: 826-830, 2008. (Pubitemid 352032408)